{"schema_version":"secwatch.filing_event.v1","accession":"0001295947-25-000007","form_type":"8-K","ticker":"PBH","cik":"0001295947","company_name":"Prestige Consumer Healthcare Inc.","filed_at":"2025-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.238185+00:00","generated_at":"2026-05-27T01:28:47.776817+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Prestige Q3 FY2025 EPS $1.22 (+15% YoY); raises FY25 adjusted EPS outlook to ~$4.50","bullets":["Q3 revenues $290.3M (+2.7% YoY); record quarterly sales and EPS.","Diluted EPS $1.22 vs $1.06 prior year; net income $61.0M vs $53.0M.","Raises FY25 adjusted EPS outlook to ~$4.50 from $4.40-$4.46; FCF ≥$240M reaffirmed.","International OTC segment grew 11.3% (8.3% ex-FX); North American OTC +1.0%.","Leverage reduced to 2.5x; repurchased 0.6M shares for ~$40.2M YTD."],"urls":{"canonical":"https://secwatch.observer/filing/0001295947-25-000007","json":"https://secwatch.observer/filing/0001295947-25-000007.json","markdown":"https://secwatch.observer/filing/0001295947-25-000007.md","text":"https://secwatch.observer/filing/0001295947-25-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1295947/000129594725000007/0001295947-25-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1295947/000129594725000007/pbh-20250206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T01:28:47.776817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}